News tagged with national cancer
DC-SCRIPT found to have prognostic value in breast cancer
Dec 14, 2009 |
not rated yet |
0
DC-SCRIPT, or dendritic cell-specific transcript, is a key regulator of nuclear receptor activity that may have prognostic value in breast cancer, according to a new study published online December 14 in the Journal of th ...
The need for cardio-oncology: Treating cancer and protecting the heart
Dec 10, 2009 |
not rated yet |
0
Cardiologists and oncologists must work together in an attempt to avoid or prevent adverse cardiovascular effects in patients from certain chemotherapies, especially for those who may be at a higher risk for such effects, ...
Dermatologic infections in cancer patients treated with EGFRI therapy
Dec 09, 2009 |
not rated yet |
0
Patients who experience dermatologic toxic effects from epidermal growth factor receptor inhibitors (EGFRIs) have a high prevalence of skin and nail infections, according to a new study published online December 9 in the ...
Higher risk for heart disease and diabetes associated with androgen deprivation therapy
Dec 07, 2009 |
not rated yet |
0
Men of all ages treated for prostate cancer with androgen deprivation therapy, specifically with gonadotropin-releasing hormone agonists (GnRH), have an increased risk of diabetes and cardiovascular disease, according to ...
No change in brain tumor incidence during a time when cell phone usage increased
Dec 03, 2009 |
not rated yet |
0
There was no substantial change in brain tumor incidence among adults 5 to 10 years after cell phone usage sharply increased, according to a new brief communication published online December 3 in the Journal of the National Ca ...
Long-term testicular cancer survivors at high risk for neurological side effects
Nov 25, 2009 |
not rated yet |
0
Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated with ...
Estrogen receptor-alpha, breast cancer patients and tamoxifen response
Nov 25, 2009 |
not rated yet |
0
Researchers have found evidence of a statistically significant survival benefit from adjuvant tamoxifen among patients whose estrogen receptor (ER)-positive tumors had high levels of phosphorylation of ER-alpha; at serine-118 ...
